• 1
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 11451147.
  • 2
    Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18: 399404.
  • 3
    Andrews PW, Bronson DL, Benham F, et al. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 1980; 26: 269280.
  • 4
    Andrews PW, Goodfellow PN, Shevinsky LH, et al. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer 1982; 29: 523531.
  • 5
    Andrews PW, Damjanov I, Simon D, et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: differentiation in vivo and in vitro. Lab Invest 1984; 50: 147162.
  • 6
    Andrews PW, Casper J, Damjanov I, et al. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 1996; 66: 806816.
  • 7
    Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978; 75: 55655569.
  • 8
    Gooi HC, Feizi T, Kapadia A, et al. Stage-specific embryonic antigen involves α1[RIGHTWARDS ARROW]3 fucosylated type 2 blood group chains. Nature 1981; 292: 156158.
  • 9
    Shevinsky LH, Knowles BB, Damjanov I, et al. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982; 30: 697705.
  • 10
    Kannagi R, Cochran NA, Ishigami F, et al. Stage-specific embryonic antigens (SSEA-3 and −4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 1983; 2: 23552361.
  • 11
    Solter D, Shevinsky LH, Knowles BB, et al. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev Biol 1979; 70: 515521.
  • 12
    Martin GR, Lock LF. Pluripotent cell lines derived from mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, section 9. In: SilverLM, MartinGR, StricklandS, eds. Teratocarcinoma Stem Cells. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1983: 635646
  • 13
    Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 1984; 103: 285293.
  • 14
    Fenderson BA, Andrews PW, Nudelman E, et al. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol 1987; 122: 2134.
  • 15
    Andrews PW, Banting GS, Damjanov I, et al. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984; 3: 347361.
  • 16
    Badcock G, Pigott C, Goepel J, et al. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulphate proteoglycan. Cancer Res 1999; 59: 47154719.
  • 17
    Andrews PW, Oosterhuis JW, Damjanov I. Cell lines from human germ cell lines. In: RobertsonEJ, eds. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford: IRL Press, 1987: 207248
  • 18
    Andrews PW, Meyer LJ, Bednarz KL, et al. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 1984; 3: 3339.
  • 19
    Williams BP, Daniels GL, Pym B, et al. Biochemical and genetic analysis of the OKa blood group antigen. Immunogenetics 1988; 27: 322329.
  • 20
    McKenzie JL, Fabre JW. Human thy-1: unusual localization and possible functional significance in lymphoid tissues. J Immunol 1981; 126: 843850.
  • 21
    Duran C, Talley PJ, Walsh J, et al. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype. Int J Cancer 2001; 93: 324332.
  • 22
    Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97: 1130711312.
  • 23
    Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990; 215: 403410.
  • 24
    Ben-Shushan E, Thompson JR, Gudas LJ, et al. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 1998; 18: 18661878.
  • 25
    Berstine EG, Hooper ML, Grandchamp S, et al. Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci USA 1973; 70: 38993903.
  • 26
    Stern PL, Martin GR, Evans MJ. Cell surface antigens of clonal teratocarcinoma cells at various stages of differentiation. Cell 1975; 6: 455465.
  • 27
    Andrews PW, Goodfellow PN, Bronson DL. Cell surface characteristics and other markers of differentiation of human teratocarcinomas in culture. In: SilverLM, MartinGR, StricklandS, eds. Teratocarcinoma Stem Cells. Cold Spring Harbor Conferences on Cell Proliferation. 1983; 10:579590.
  • 28
    Collignon J, Sockanathan S, Hacker A, et al. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 1996; 122: 509520.
  • 29
    Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990; 345: 686692.
  • 30
    Fraidenraich D, Lang R, Basilico C. Distinct regulatory elements govern Fgf4 gene expression in the mouse blastocyst, myotomes, and developing limb. Dev Biol 1998; 204: 197209.
  • 31
    Heikinheimo O, Dong KW, Lanzendorf SE, et al. Primate reproductive organs reveal a novel pattern of proto-oncogene c-mos and transcription factor Oct-3 mRNA expression. Mol Reprod Dev 1995; 42: 397406.
  • 32
    Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells. Diabetes 2001; 50: 16911697.
  • 33
    Peschle C, Mavilio F, Care A, et al. Haemoglobin switching in human embryos: asynchrony of zeta—alpha and epsilon—gamma-globin switches in primitive and definite erythropoietic lineage. Nature 1985; 313: 235238.
  • 34
    Gitlin D, Boesman MJ. Sites of serum alpha-fetoprotein synthesis in the human and in the rat. J Clin Invest 1967; 46: 10101016.
  • 35
    Midgley AR, Pierce GB. Immunohistochemical localization of human chorionic gonadotropin. J Exp Med 1962; 115: 284294.
  • 36
    Pevny LH, Sockanathan S, Placzek M, et al. A role for SOX1 in neural determination. Development 1998; 125: 19671978.
  • 37
    Lee JE, Hollenberg SM, Snider L, et al. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995; 268: 836844.
  • 38
    Rogers MB, Hosler BA, Gudas LJ. Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 1991; 113: 815824.
  • 39
    McGrath J, Solter D. Nuclear transplantation in mouse embryos. J Exp Zool 1983; 228: 355362.
  • 40
    Fenderson BA, Andrews PW. Carbohydrate antigens of embryonal carcinoma cells: changes upon differentiation. APMIS 1992; 100 (suppl 27):109118.
  • 41
    Willison KR, Karol RA, Suzuki A, et al. Neutral glycolipid antigens as developmental markers of mouse teratocarcinoma and early embryos: an immunologic and chemical analysis. J Immunol 1982; 129: 603609.
  • 42
    Krupnick JG, Damjanov I, Damjanov A, et al. Globo-series carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells. Int J Cancer 1994; 59: 692698.
  • 43
    Chen C, Fenderson BA, Andrews PW, et al. Glycolipid glycosyltransferases in human embryonal carcinoma cells during retinoic acid-induced differentiation. Biochemistry 1989; 28: 22292238.
  • 44
    Fenderson BA, Radin N, Andrews PW. Differentiation antigens of human germ cell tumours: distribution of carbohydrate epitopes on glycolipids and glycoproteins analysed using PDMP, an inhibitor of glycolipid synthesis. Eur Urol 1993; 2: 3037.
  • 45
    Childs RA, Pennington J, Uemura K, et al. High-molecular-weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i and SSEA-1 of mouse teratocarcinoma cells. Biochem J 1983; 215: 491503.
  • 46
    Ozawa M, Muramatsu T, Solter D. SSEA-1, a stage-specific embryonic antigen of the mouse, is carried by the glycoprotein-bound large carbohydrate in embryonal carcinoma cells. Cell Diff 1985; 16: 169173.
  • 47
    Rosenman SJ, Fenderson BA, Hakormori S-I. Murine embryonal carcinoma cell-surface sialyl LeX is present on a novel glycoprotein and on high-molecular-weight lactosaminoglycan. Exp Cell Res 1989; 180: 326340.
  • 48
    Fenderson BA, Zehavi U, Hakomori S. A multivalent lacto-n-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med 1984; 160: 15911596.
  • 49
    Bird JM, Kimber SJ. Oligosaccharides containing fucose linked α(1[RIGHTWARDS ARROW]3) and α(1[RIGHTWARDS ARROW]4) to N-acetylglucosamine cause decompaction of mouse morulae. Dev Biol 1984; 104: 449460.
  • 50
    Fenderson BA, Ostrander GK, Hausken Z, et al. A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos. Exp Cell Res 1992; 198: 362366.
  • 51
    Tippett P, Andrews PW, Knowles BB, et al. Red cell antigens P (globoside) and Luke: identification by monoclonal antibodies defining the murine stage-specific embryonic antigens −3 and −4 (SSEA-3 and SSEA-4). Vox Sang 1986; 51: 5356.
  • 52
    Race RR, Sanger R. The P Blood Groups. In: Blood Groups in Man, Sixth Edition. Oxford, UK: Blackwell Scientific, 1975: 139168
  • 53
    Andrews PW. Teratocarcinomas and human embryology: pluripotent human EC cell lines. APMIS 1998; 106: 158168.